CIK 0000899923
- Accelerated filer
MYRIAD GENETICS INC
Sign in to watch- Ticker
- MYGN
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 870494517
- Phone
- +1 801-584-3600
- Business address
- 322 NORTH 2200 WEST, SALT LAKE CITY, UT, 84116
- Former names
- MYRIAD GENETICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $34,252
- in 1 filing
Net −$34,252. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2015-12-03 | BEST LAWRENCE C Director | Grant or award | +7,500 | 17,500 | ||
| 2015-11-05 | DREISMANN HEINRICH Director | Exercise or conversion | +30,000 | $25.39 | $762K | 40,000 |
| 2015-11-05 | DREISMANN HEINRICH Director | Sale | −30,000 | $44.44 | $1.3M | 10,000 |
| 2015-11-05 | DREISMANN HEINRICH Director | Exercise or conversion | +30,000 | $27.61 | $828K | 40,000 |
| 2015-11-05 | DREISMANN HEINRICH Director | Sale | −30,000 | $44.44 | $1.3M | 10,000 |
| 2015-11-05 | DREISMANN HEINRICH Director | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −30,000 | 0 | ||
| 2015-11-05 | DREISMANN HEINRICH Director | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −30,000 | 0 | ||
| 2015-11-04 | MARSH RICHARD M E.V.P., General Counsel | Gift | −1,739 | 68,384 | ||
| 2015-11-04 | MARSH RICHARD M E.V.P., General Counsel | Exercise or conversion | +35,000 | $22.93 | $803K | 103,384 |
| 2015-11-04 | MARSH RICHARD M E.V.P., General Counsel | Sale | −35,000 | $44.50 | $1.6M | 68,384 |
| 2015-11-04 | MARSH RICHARD M E.V.P., General Counsel | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −35,000 | 0 | ||
| 2015-10-28 | King Gary A. Exec. VP International Ops | Exercise or conversion | +10,000 | $23.98 | $240K | 90,573 |
| 2015-10-28 | King Gary A. Exec. VP International Ops | Sale | −10,000 | $42.82 | $428K | 80,573 |
| 2015-10-28 | King Gary A. Exec. VP International Ops | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −10,000 | 11,830 | ||
| 2015-10-28 | LANCHBURY JERRY S Chief Scientific Officer | Exercise or conversion | +50,962 | $22.93 | $1.2M | 121,699 |
| 2015-10-28 | LANCHBURY JERRY S Chief Scientific Officer | Sale | −50,962 | $41.86 | $2.1M | 70,737 |
| 2015-10-28 | LANCHBURY JERRY S Chief Scientific Officer | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −50,962 | 0 | ||
| 2015-10-27 | LANCHBURY JERRY S Chief Scientific Officer | Exercise or conversion | +7,298 | $16.53 | $121K | 78,035 |
| 2015-10-27 | LANCHBURY JERRY S Chief Scientific Officer | Sale | −7,298 | $41.80 | $305K | 70,737 |
| 2015-10-27 | LANCHBURY JERRY S Chief Scientific Officer | Exercise or conversion | +5,038 | $22.93 | $116K | 75,775 |
Page 51 of 60 · 1,194 trades